Clinical Trials Browser

Phase 2 × Not yet recruiting × HER2-positive Gastric Cancer × Clear all

NCT06492317 2024-07-09

RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric Cancer

Phase 2 Not yet recruiting

Gastrointestinal

HER2-positive Gastric Cancer

NCT06439550 2024-06-03

Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJC

Phase 2 Not yet recruiting

Gastrointestinal

HER2-positive Gastric Cancer